<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00858520</url>
  </required_header>
  <id_info>
    <org_study_id>B32220072389</org_study_id>
    <secondary_id>S50623</secondary_id>
    <nct_id>NCT00858520</nct_id>
  </id_info>
  <brief_title>Serum, Plasma, DNA and Tissue Bank in Chronic Obstructive Pulmonary Disease and Lung Cancer</brief_title>
  <official_title>Serum, Plasma, DNA and Tissue Bank of Patients With Chronic Obstructive Pulmonary Disease, Lung Cancer and Smoking Controls.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A biobank of Serum, plasma, DNA samples together with clinical information including specific
      questionnaires, complete pulmonary function and chest CT-scan, is prospectively collected in
      patients seen at the investigators' clinical service.

      The objective is to study candidate gene pathways in COPD and or lung cancer and to associate
      them with the clinical characteristics and phenotypes of COPD/emphysema and lung cancer.

      In subgroups of well characterised patients, other biological materials are also collected
      (lung tissue biopsies, peripheral blood mononuclear cells).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients with a smoking history of at least 15 pack years, an minimal age of 50 years and
      an recent available CT scan are enrolled.

      All subjects with a diagnosis of lung cancer are also collected (irrespective of age and
      smoking behavior).

      In addition the investigators collect:

        -  specific questionnaires (MRC, CCQ and smoking history)

        -  medical and professional history

        -  complete pulmonary function (spirometry, bodyplethysmography and diffusing capacity)

        -  serum, plasma and DNA samples.

      In specific subgroups the investigators also collect:

        -  Peripheral blood mononuclear cells

        -  Lung tissue - if available - from a surgical procedure (lung transplantation or
           lobectomy)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serological, cytological, histological and genetic analysis of biomarkers or genes which are involved in the pathogenesis of COPD/Emphysema/Lungcancer.</measure>
    <time_frame>0-1-3-6 years</time_frame>
    <description>All cases are prospectively collected in University hospital Leuven, Belgium. Of enrolled subjects data are collected at 0,1,3 and 6 years interval</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Smoking controls</arm_group_label>
    <description>Smokers without lung cancer and without COPD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD patients</arm_group_label>
    <description>Smokers with COPD but without lung cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lung cancer patients</arm_group_label>
    <description>smokers - never smokers with lung cancer</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Germline DNA, serum and plasma, Peripheral blood mononuclear cells, Lung tissue biopsies
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Chronic Obstructive Pulmonary Disease and smoking controls.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for smokers:

          -  A smoking history of at least 15 pack years and age of 50 years or older

          -  Complete pulmonary function on day of visit

          -  Chest CT-scan within one year of enrollment

          -  4 weeks from exacerbation

        Exclusion Criteria for smokers:

          -  Less than 15 pack years

          -  Younger than 50 year

          -  Other pulmonary diseases interfering with CT or pulmonary function

          -  Asthma

        Inclusion Criteria for lung cancer patients:

          -  new diagnosis of proven lung cancer

          -  chest CT scan within 2 months of enrollment

          -  Complete pulmonary function

        Exclusion Criteria for lung cancer patients

          -  not able to perform pulmonary function

          -  Absence of histological diagnosis of lung cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wim Janssens, MD. PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Katholieke Universiteit Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wim Janssens, MD. PhD.</last_name>
    <phone>032 (16) 34 68 00</phone>
    <email>wim.janssens@uz.kuleuven.ac.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristien Debent</last_name>
    <phone>032 (16) 34 31 26</phone>
    <email>kristien.debent@uz.kuleuven.ac.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Katholieke Universiteit Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Flanders</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wim Janssens, Prof</last_name>
      <phone>032 (16) 34 68 00</phone>
      <email>wim.janssens@uz.kuleuven.ac.be</email>
    </contact>
    <investigator>
      <last_name>Wim Janssens, MD. PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc Decramer, MD. PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Diether Lambrechts, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Johan Vansteenkiste, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul Deleyn, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2009</study_first_submitted>
  <study_first_submitted_qc>March 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2009</study_first_posted>
  <last_update_submitted>September 2, 2013</last_update_submitted>
  <last_update_submitted_qc>September 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Marc Decramer</investigator_full_name>
    <investigator_title>Prof.Dr.</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>Lung cancer</keyword>
  <keyword>genes</keyword>
  <keyword>DNA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

